The estimated Net Worth of Baisong Mei is at least 775 千$ dollars as of 4 September 2024. Baisong Mei owns over 518 units of Editas Medicine Inc stock worth over 506,123$ and over the last 2 years Baisong sold EDIT stock worth over 268,537$.
Baisong has made over 5 trades of the Editas Medicine Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Baisong sold 518 units of EDIT stock worth 1,772$ on 4 September 2024.
The largest trade Baisong's ever made was selling 20,327 units of Editas Medicine Inc stock on 2 March 2024 worth over 191,480$. On average, Baisong trades about 4,613 units every 59 days since 2022. As of 4 September 2024 Baisong still owns at least 133,895 units of Editas Medicine Inc stock.
You can see the complete history of Baisong Mei stock trades at the bottom of the page.
Baisong's mailing address filed with the SEC is C/O EDITAS MEDICINE, INC., 11 HURLEY ST., CAMBRIDGE, MA, 02141.
Over the last 9 years, insiders at Editas Medicine Inc have traded over 73,429,036$ worth of Editas Medicine Inc stock and bought 241,700 units worth 4,697,822$ . The most active insiders traders include Andrew A. F. Hack、Kevin P Starr、Kevin Bitterman. On average, Editas Medicine Inc executives and independent directors trade stock every 22 days with the average trade being worth of 126,770$. The most recent stock trade was executed by Baisong Mei on 4 September 2024, trading 518 units of EDIT stock currently worth 1,772$.
unlocking the promise of genome editing to deliver life-changing medicines. editas medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
Editas Medicine Inc executives and other stock owners filed with the SEC include: